Rodriguez-Garcia E - Search Results

1

Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy.

Nistal-Villán E, Argemi J, de Jaime-Soguero A, Ferrero R, di Scala M, Rodriguez-Garcia E, Coll A, Rius-Rocabert S, Prieto J, González-Aseguinolaza G, Aragón T. Nistal-Villán E, et al. Hum Gene Ther. 2021 Apr;32(7-8):341-348. doi: 10.1089/hum.2019.336. Epub 2021 Jan 22. Hum Gene Ther. 2021. PMID: 33213214

2

Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis.

Gil-Farina I, Di Scala M, Salido E, López-Franco E, Rodríguez-García E, Blasi M, Merino J, Aldabe R, Prieto J, Gonzalez-Aseguinolaza G. Gil-Farina I, et al. J Immunol. 2016 Sep 15;197(6):2145-56. doi: 10.4049/jimmunol.1600228. Epub 2016 Aug 10. J Immunol. 2016. PMID: 27511737

3

TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway.

Rodríguez-García E, Olagüe C, Ríus-Rocabert S, Ferrero R, Llorens C, Larrea E, Fortes P, Prieto J, González-Aseguinolaza G, Nistal-Villan E. Rodríguez-García E, et al. Immunohorizons. 2018 Dec 11;2(11):363-376. doi: 10.4049/immunohorizons.1800068. Immunohorizons. 2018. PMID: 31026807 Free article.

4

A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response.

Nistal-Villán E, Rodríguez-García E, Di Scala M, Ferrero-Laborda R, Olagüe C, Vales Á, Carte-Abad B, Crespo I, García-Sastre A, Prieto J, Larrea E, González-Aseguinolaza G. Nistal-Villán E, et al. J Innate Immun. 2015;7(5):466-81. doi: 10.1159/000375262. Epub 2015 May 5. J Innate Immun. 2015. PMID: 25966783 Free PMC article.

5

A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling.

Nistal-Villan E, Poutou J, Rodríguez-Garcia E, Buñuales M, Carte-Abad B, Prieto J, Gonzalez-Aseguinolaza G, Hernandez-Alcoceba R, Larrea E. Nistal-Villan E, et al. PLoS One. 2016 Mar 23;11(3):e0152031. doi: 10.1371/journal.pone.0152031. eCollection 2016. PLoS One. 2016. PMID: 27007218 Free PMC article.

6

Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5^ch and AAV1.

Majowicz A, Salas D, Zabaleta N, Rodríguez-Garcia E, González-Aseguinolaza G, Petry H, Ferreira V. Majowicz A, et al. Mol Ther. 2017 Aug 2;25(8):1831-1842. doi: 10.1016/j.ymthe.2017.05.003. Epub 2017 Jun 5. Mol Ther. 2017. PMID: 28596114 Free PMC article.

7

Optimising the IgG-degrading enzyme treatment regimen for enhanced adeno-associated virus transduction in the presence of neutralising antibodies.

Ros-Gañán I, Hommel M, Trigueros-Motos L, Tamarit B, Rodríguez-García E, Salas D, Pérez G, Douar A, Combal JP, Benichou B, Ferrer V, González-Aseguinolaza G. Ros-Gañán I, et al. Clin Transl Immunology. 2022 Feb 24;11(2):e1375. doi: 10.1002/cti2.1375. eCollection 2022. Clin Transl Immunology. 2022. PMID: 35228870 Free PMC article.

8

AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production.

Rodriguez-Garcia E, Zabaleta N, Gil-Farina I, Gonzalez-Aparicio M, Echeverz M, Bähre H, Solano C, Lasa I, Gonzalez-Aseguinolaza G, Hommel M. Rodriguez-Garcia E, et al. J Immunol. 2021 Jan 15;206(2):376-385. doi: 10.4049/jimmunol.2000953. Epub 2020 Dec 9. J Immunol. 2021. PMID: 33298616

9

Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants.

Conde E, Vercher E, Soria-Castellano M, Suarez-Olmos J, Mancheño U, Elizalde E, Rodriguez ML, Glez-Vaz J, Casares N, Rodríguez-García E, Hommel M, González-Aseguinolaza G, Uranga-Murillo I, Pardo J, Alkorta G, Melero I, Lasarte J, Hervas-Stubbs S. Conde E, et al. J Immunother Cancer. 2021 Nov;9(11):e003351. doi: 10.1136/jitc-2021-003351. J Immunother Cancer. 2021. PMID: 34810235 Free PMC article.

10

Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming.

Hervas-Stubbs S, Riezu-Boj JI, Mancheño U, Rueda P, Lopez L, Alignani D, Rodríguez-García E, Thieblemont N, Leclerc C. Hervas-Stubbs S, et al. J Immunol. 2014 Aug 1;193(3):1151-61. doi: 10.4049/jimmunol.1301440. Epub 2014 Jun 27. J Immunol. 2014. PMID: 24973449 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters